SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-15-076519
Filing Date
2015-11-06
Accepted
2015-11-06 10:31:35
Documents
11
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a15-17918_110q.htm 10-Q 1100508
2 EX-31.1 a15-17918_1ex31d1.htm EX-31.1 10256
3 EX-31.2 a15-17918_1ex31d2.htm EX-31.2 11007
4 EX-32.1 a15-17918_1ex32d1.htm EX-32.1 4031
5 EX-32.2 a15-17918_1ex32d2.htm EX-32.2 4030
  Complete submission text file 0001104659-15-076519.txt   5305515

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT stml-20150930.xml EX-101.INS 1259904
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT stml-20150930.xsd EX-101.SCH 40489
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT stml-20150930_cal.xml EX-101.CAL 38851
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT stml-20150930_def.xml EX-101.DEF 120520
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT stml-20150930_lab.xml EX-101.LAB 388934
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT stml-20150930_pre.xml EX-101.PRE 262579
Mailing Address 750 LEXINGTON AVENUE NEW YORK NY 10022
Business Address 750 LEXINGTON AVENUE ELEVENTH FLOOR NEW YORK NY 10022 646-502-2311
STEMLINE THERAPEUTICS INC (Filer) CIK: 0001264587 (see all company filings)

IRS No.: 450522567 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35619 | Film No.: 151202900
SIC: 2834 Pharmaceutical Preparations